Genmab A/S

GMAB chart

Genmab A/S news

• J.P. Morgan upgrades Genmab on cancer drug growth potential

  Yahoo Finance · Oct 27, 7:11 AM EDT

• Genmab A/S (GMAB) Stock Price | Live Quotes & Charts | NASDAQ

  Timothy Sykes · Oct 26, 8:30 PM EDT

• Petosemtamab Trial Results May Change The Case For Genmab Stock

  Yahoo Finance · Oct 26, 7:23 PM EDT

• Genmab Phase 2 Trial Reports 28.2-Month Cancer Survival

  grafa.com · Oct 26, 11:23 AM EDT

• Genmab's Encouraging Oncology Data Boosts Investor Optimism

  Yahoo Finance · Oct 26, 11:08 AM EDT

• Incyte & Genmab Collaborate to Develop a New Colorectal Cancer Therapy

  Yahoo Finance · Oct 26, 10:25 AM EDT

• Immuno-Oncology Emerges as a Major Force in the Global Cancer Treatment Market

  The Manila Times · Oct 26, 9:04 AM EDT

• Genmab Announces Updated Phase 2 Data Demonstrating More Than Two-Year Median Overall Survival with Petosemtamab Plus Pembrolizumab in First-Line Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

  Yahoo Finance · Oct 26, 7:00 AM EDT

• Genmab Announces Updated Phase 2 Data Demonstrating More

  GlobeNewswire · Oct 26, 7:00 AM EDT

• Genmab Soars as Cancer Drug Impresses in a Late-Stage Trial

  Bloomberg.com · Oct 26, 6:01 AM EDT

• Genmab shares jump 13% on colorectal cancer drug trial results

  Yahoo Finance · Oct 26, 5:18 AM EDT

• Weekly Recap: OS gain in Genmab and petosemtamab+INCB161734 Phase1/2

  TradingView · Oct 26, 1:00 AM EDT

Genmab A/S key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-K6-K2026-10-23
• 6-K6-K2026-10-13
• 6-K6-K2026-10-07
• 6-K6-K2026-10-05
• 6-K6-K2026-10-02
• 6-K6-K2026-09-29
• 6-K6-K2026-09-24
• 6-K6-K2026-09-09
• 6-K6-K2026-09-09
• 6-K6-K2026-09-08
• 6-K6-K2026-08-12
• 6-K6-K2026-08-11

About Genmab A/S

Ticker

GMAB (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

1253 Copenhagen K, Denmark

SEC CIK

1434265

Frequently asked questions